Prostate Cancer - Results from #22980

A personalised approach to prostate cancer screening based on genotyping of risk founder alleles - Abstract July 15, 2013

Usefulness of bone turnover markers as predictors of mortality risk, disease progression and skeletal-related events appearance in patients with prostate cancer with bone metastases following treatment with zoledronic acid: TUGAMO study - Abstract July 15, 2013

Imaging appearance of sarcomas of the prostate - Abstract July 15, 2013

The surgical approach can be determined from the pathological specimen obtained after open or robot-assisted laparoscopic radical prostatectomy - Abstract July 15, 2013

Impact of cabazitaxel on 2-year survival and palliation of tumour-related pain in men with metastatic castration-resistant prostate cancer treated in the TROPIC trial - Abstract July 15, 2013

Plasma phospholipid fatty acids and prostate cancer risk in the SELECT trial - Abstract July 13, 2013

MR-CT registration using a Ni-Ti prostate stent in image-guided radiotherapy of prostate cancer - Abstract July 12, 2013

The role of robot-assisted radical prostatectomy and pelvic lymph node dissection in the management of high-risk prostate cancer: A systematic review - Abstract July 12, 2013

Functional and molecular imaging: Applications for diagnosis and staging of localised prostate cancer - Abstract July 12, 2013

Dietary flavonoid intake, black tea consumption, and risk of overall and advanced stage prostate cancer - Abstract July 12, 2013

Quality of care indicators and their related outcomes: A population-based study in prostate cancer patients treated with radiotherapy - Abstract July 12, 2013

Age remains the major predictor of curative treatment non-receipt for localised prostate cancer: A population-based study - Abstract July 12, 2013

Serum sarcosine is a risk factor for progression and survival in patients with metastatic castration-resistant prostate cancer - Abstract July 12, 2013

Clinical predictors of survival in men with castration-resistant prostate cancer: Evidence that Gleason score 6 cancer can evolve to lethal disease - Abstract July 12, 2013

Management of biochemical recurrence after primary treatment of prostate cancer: A systematic review of the literature - Abstract July 12, 2013

Potential value of Gleason score in predicting the benefit of cabazitaxel in metastatic castration-resistant prostate cancer - Abstract July 11, 2013

Successful treatment with docetaxel and prednisolone for paxlitaxel and carboplatin-resistant prostate cancer - Abstract July 11, 2013

Transrectal electrical impedance tomography of the prostate: Spatially coregistered pathological findings for prostate cancer detection - Abstract July 11, 2013

Development of the Men's Prostate Awareness Church Training: Church-based workshops for African American men - Abstract July 11, 2013

The Prostate Cancer Prevention Trial risk calculator and the relationship between prostate-specific antigen and biopsy outcome - Abstract July 11, 2013

Page 1150 of 1447